Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-12-16
2009-12-08
Chong, Yong S. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S406000, C514S403000
Reexamination Certificate
active
07629375
ABSTRACT:
Cytoprotective compounds, many of which are phenolic derivatives characterized by a substituted phenol having certain conjugated bonds, are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders characterized by inflammation or oxidative damage. They are also useful in the manufacture of pharmaceutical and cosmetic formulations for the treatment of such conditions.
REFERENCES:
patent: 4743606 (1988-05-01), Lazer
patent: 4812460 (1989-03-01), Lazer
patent: 4877881 (1989-10-01), Belliotti et al.
patent: 4992468 (1991-02-01), Chandraratna
patent: 5068252 (1991-11-01), Chandraratna
patent: 5208250 (1993-05-01), Cetenko et al.
patent: 5302606 (1994-04-01), Spada et al.
patent: 5306822 (1994-04-01), Cetenko et al.
patent: 5326898 (1994-07-01), Chandraratna
patent: 5356917 (1994-10-01), Paneta
patent: 5360924 (1994-11-01), Beller et al.
patent: 5378705 (1995-01-01), Klaus et al.
patent: 5416112 (1995-05-01), Kuo
patent: 5418245 (1995-05-01), Spada et al.
patent: 5430062 (1995-07-01), Cushman et al.
patent: 5464856 (1995-11-01), Cetenko et al.
patent: 5489614 (1996-02-01), Korkolainen et al.
patent: 5530157 (1996-06-01), Mewshaw et al.
patent: 5547983 (1996-08-01), Charpentier
patent: 5565191 (1996-10-01), Raspanti
patent: 5614541 (1997-03-01), Backstrom et al.
patent: 5827898 (1998-10-01), Khandwala et al.
patent: 5844004 (1998-12-01), Muller et al.
patent: 5854285 (1998-12-01), Sriram et al.
patent: 5889037 (1999-03-01), Backstrom et al.
patent: 5952390 (1999-09-01), Muller et al.
patent: 6117911 (2000-09-01), Grainger et al.
patent: 6121303 (2000-09-01), Backstrom et al.
patent: 6127426 (2000-10-01), Muller et al.
patent: 6147121 (2000-11-01), Breton et al.
patent: 6165998 (2000-12-01), Wobbe et al.
patent: 6194453 (2001-02-01), Sriram et al.
patent: 6224854 (2001-05-01), Robinson
patent: 6245774 (2001-06-01), Warrellow et al.
patent: 6407142 (2002-06-01), Courbriere et al.
patent: 6462075 (2002-10-01), Bowen et al.
patent: 6552085 (2003-04-01), Inman et al.
patent: 6610877 (2003-08-01), Klaus et al.
patent: 6624182 (2003-09-01), Haap et al.
patent: 2002/0025975 (2002-02-01), Nag et al.
patent: 2002/0032225 (2002-03-01), Nag et al.
patent: 2002/0045620 (2002-04-01), Druzgala et al.
patent: 2002/0051799 (2002-05-01), Pruche et al.
patent: 2003/0118617 (2003-06-01), Soby et al.
patent: 2003/0144363 (2003-07-01), Liviero et al.
patent: 2003/0144525 (2003-07-01), Alanine et al.
patent: 2003/0149003 (2003-08-01), Chaplin et al.
patent: 2003/0171429 (2003-09-01), Chen et al.
patent: 10 38 050 (1958-09-01), None
patent: 0 322 738 (1989-07-01), None
patent: 0334119 (1989-09-01), None
patent: 0 391 644 (1990-10-01), None
patent: 1016654 (2000-07-01), None
patent: 2169334 (1973-09-01), None
patent: 52005751 (1977-01-01), None
patent: 52083360 (1977-07-01), None
patent: 52083361 (1977-07-01), None
patent: 10175854 (1988-06-01), None
patent: 04089436 (1992-03-01), None
patent: 05032587 (1993-02-01), None
patent: 06072866 (1994-03-01), None
patent: 07053359 (1995-02-01), None
patent: 10017455 (1998-01-01), None
patent: 10072330 (1998-03-01), None
patent: 10087641 (1998-04-01), None
patent: 10175852 (1998-06-01), None
patent: 10017455 (1999-01-01), None
patent: 11060537 (1999-03-01), None
patent: 10335472 (2001-12-01), None
patent: WO/96/20936 (1996-07-01), None
patent: WO/98/46588 (1998-10-01), None
patent: WO/99/01148 (1999-01-01), None
patent: WO/99/04747 (1999-02-01), None
patent: WO/99/58127 (1999-11-01), None
patent: WO/00/04889 (2000-02-01), None
patent: WO/00/19989 (2000-04-01), None
patent: WO/00/21368 (2000-04-01), None
patent: WO/00/45782 (2000-08-01), None
patent: WO/01/42231 (2001-06-01), None
patent: WO/01/43705 (2001-06-01), None
patent: WO/02/057219 (2002-07-01), None
Trusevich et al. (1980) “Synthesis And Spectrometric Study Of 2,4,5-Substituted Pyrazol-3-One” Urk. Khin. Kh. (Russ. Ed.) 46(6):642-645 (abstract only).
Li et al. (2002) “Syntesis of Water-Soluble Optically Nonlinear Materials Based On Trans-Distyrylbenzene” Youji Huaxue 22(2):141-144 (abstract only).
Bonina et al. (1987) “Synthesis and Analgesic Anti-Inflammatory Activities of 2-Arylethenyl-4-Arylthiazole-5-Acetic Acids” Farmaco. Ed. Sci. 42(12)905-913.
Bonina et al. (1985) “Synthesis and Pharmacological Activities of 2-Arylethenyl-thiazole-4-Acetic and 4-carboxylic Acids” Farmaco. Ed. Sci. 40(11):875-884 (abstract only).
Walter et al. (1966) “Synthesis and Cyclization Reactions of 3-(2-Hydroxybenzylidene)-2(3H0-Coumarones” Journal of Organic Chemistry 31(11):3854-3857.
Lazer et al. (1989) “Antiinflammatory 2.6-Di-tert-butyl-4-(2-arylthenyl)phenois” J. Med. Chem. 32:100-104.
Aihara et al. (1990) “Increasing 5-Lipoxygenase Inhibitory Activities By Oxidative Conversion of 0-Methoxyphenois To Catechols Using a Cu2+ -Ascorbic Acid-O2 System” Chem. Pharm. Bull. 38(3):842-844.
Flynn et al. (1991) “Styrylpyrazoles, Styryloxazoles, Styrylisothiazoles. Novel 5-Lipoxygenase and Cyclooxygenase Inhibitors” J. Med. Chem. 34:518-525.
Cushman et al. (1991) “Synthesis and evaluation of Stilbene and Dihydrostibene Derivatives as Potential Anticancer Agents That Inhibit Tubulin Polymerization” J. Med. Chem. 34:2579-2588.
Unangst et al. (1992) “Synthesis and Transformations of 2,6-Bis(1,1-dimethylethyl)-4-[2-(thiazolyl)ethenyl]phenois” J. Heterocyclic Chem. 29:1097-1100.
Farina et al. (1993) “A Prodrug of a 2,6-Disubstituted 4-(2-Arylethenyl)phenol is a Selective and Orally Active 5-Lipoxygenase Inhibitor”, The Journal of Pharmacology and Experimental Therapeutics 265(2):483-489.
Treadwell et al. (1999) “Synthesis of Schweinfurthin C, a Geranylated Stilbene from Macaranga schweinfurthii” J. Org. chem. 64:8718-8723.
Shukla et al. (1999) “Dinuclear Complexes of a New Bridging Ligand Containing 2,2-Bipyridyl and Dioxolene Binding Sites; Syntheses, Electrochemical and Electronic Spectroscopic Properties” Inorganica Chemica Acta. 285:89-96.
Hung et al. (2001) “Beneficial Effects of Astringinin, a Resveratrol Analogue, on the Ischemia and Reperfusion Damage in Rat Heart” Free Radical Biology and Medicine 30(8):877-883.
Cotias et al. Longistyline C, antibiotic isolated fromLonchocarpus longistyllus.Preliminary results of its pharmacological properties. (1979) Revista ed Quimica Industrial (Rio de Janeiro) 48(564):12-15 (abstract
o translation).
Christensen et al. “Excelsaoctaphenol, a stilbene dimer fromChlorophora excelsa” (1989) Phytochemistry 28(3):917-918.
Marta et al. “Synthesis of longistylin A, B, C, D and other new prenylated stilbenes” (1979) Gazzetta Chemica Italiana 109(6-7) 323-324.
Gierer et al. Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry (1974) 28(7):717-729 (abstract).
Minn et al. J. of Agricultural and Food Chem (1996) 44(1):2946-2947 (abstract).
Bobzin Steven
Boddupalli Sekhar
Brown Lesley
Chen Jian
Del Balzo Ughetta
Chong Yong S.
Johnson & Johnson Consumer Companies Inc.
LandOfFree
Cytoprotective compounds, pharmaceutical and cosmetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytoprotective compounds, pharmaceutical and cosmetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytoprotective compounds, pharmaceutical and cosmetic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4098711